This opinion piece aims to situate the placebo effect within the field of psychiatric treatment. To accomplish this, the placebo is explored at the centre of an often heated debate between three discrete perspectives: the clinical trial researcher, the placebo researcher and the clinician. Each occupational perspective has its own vested interests and practical concerns that drive how the placebo concepts are negotiated and applied. It is argued that because the trial and placebo researchers typically represent opposing viewpoints, clinicians are generally uncomfortable or even baffled by placebo concepts, and this three-way tension has crucial implications for the field's progress.
- Informed Consent
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- Placebo effects and the molecular biological components involved
- The placebo effect: powerful, powerless or redundant?
- Informed consent and clinical trials: where is the placebo effect?
- What do we really know about the deliberate use of placebos in clinical practice?
- Randomised placebo-controlled trials of surgery: ethical analysis and guidelines
- The ethics of the placebo in clinical practice revisited
- Placebo response in trials of drug treatments for cancer-related fatigue: a systematic review, meta-analysis and meta-regression
- When placebo controlled trials are essential and equivalence trials are inadequate
- The art of medicine in treating osteoarthritis: I will please
- Placebo: the lie that comes true?